These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17420338)

  • 1. Mechanism(s) of systolic blood pressure reduction and drug therapy in hypertension.
    Safar ME
    Hypertension; 2007 Jul; 50(1):167-71. PubMed ID: 17420338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Course of hypertension and the potentials for regression].
    Shkhvatsabaia IK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):5-12. PubMed ID: 6212068
    [No Abstract]   [Full Text] [Related]  

  • 3. [[Antihypertensive therapy and organ protection].
    Stella ML; Grassi G; Paleari F; Gamba P; Mancia G
    Cardiologia; 1996 May; 41 Suppl 1():19-23. PubMed ID: 8831177
    [No Abstract]   [Full Text] [Related]  

  • 4. Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE).
    Papademetriou V; Farsang C; Elmfeldt D; Hofman A; Lithell H; Olofsson B; Skoog I; Trenkwalder P; Zanchetti A;
    J Am Coll Cardiol; 2004 Sep; 44(6):1175-80. PubMed ID: 15364316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute blood pressure reduction in the presence of hypertensive cardiac hypertrophy: any interference with coronary circulation?
    Guazzi MD; Alimento M; Guazzi M; Maltagliati A; Pepi M
    Scand J Clin Lab Invest Suppl; 1989; 196():53-61. PubMed ID: 2530622
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methods for studying vasodilator agents in arterial hypertension].
    Laurent S; Asmar R; Pannier B; London G; Safar M
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():69-73. PubMed ID: 2140502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension treatment in the elderly: a SPRINT to the finish.
    Parsons C; Mookadam F; Mookadam M
    Future Cardiol; 2017 Mar; 13(2):99-102. PubMed ID: 28185469
    [No Abstract]   [Full Text] [Related]  

  • 8. [The heart and essential hypertension].
    Amodeo C; Frohlich ED
    Arq Bras Cardiol; 1985 Jan; 44(1):53-5. PubMed ID: 2933013
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood pressure management in acute stroke.
    Urrutia VC; Wityk RJ
    Crit Care Clin; 2006 Oct; 22(4):695-711; abstract ix. PubMed ID: 17239750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Only systolic hypertension?
    Escobar C; Echarri R; Barrios V
    Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):143. PubMed ID: 19574290
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihypertensive therapy and de-stiffening of the arteries.
    Safar ME; Jankowski P
    Expert Opin Pharmacother; 2010 Nov; 11(16):2625-34. PubMed ID: 20977399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and pathogenetic aspects of blood pressure variability in hypertension].
    Barsukov AV; Goriacheva AA
    Kardiologiia; 2003; 43(2):82-6. PubMed ID: 12913993
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced hemodynamic load aids low-dose resveratrol in reversing cardiovascular defects in hypertensive rats.
    Thandapilly SJ; Louis XL; Behbahani J; Movahed A; Yu L; Fandrich R; Zhang S; Kardami E; Anderson HD; Netticadan T
    Hypertens Res; 2013 Oct; 36(10):866-72. PubMed ID: 23784505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is systolic pressure a better target for antihypertensive treatment than diastolic pressure?
    Leonetti G; Cuspidi C; Facchini M; Stramba-Badiale M
    J Hypertens Suppl; 2000 Jul; 18(3):S13-20. PubMed ID: 10952083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of hypertension in adults with chronic kidney disease in the United States.
    Peralta CA; Hicks LS; Chertow GM; Ayanian JZ; Vittinghoff E; Lin F; Shlipak MG
    Hypertension; 2005 Jun; 45(6):1119-24. PubMed ID: 15851626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of arterial compliance in the physiopharmacological approach to human hypertension.
    Simon AC; Levenson J; Chau NP; Pithois-Merli I
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S11-20. PubMed ID: 1381785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan and stroke reduction in the ONTARGET trial: benefit beyond blood pressure lowering?
    Serebruany VL; Atar D; Hanley DF
    Cerebrovasc Dis; 2008; 26(5):563-4. PubMed ID: 18936537
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of blood pressure after stroke.
    Bath PM; Sprigg N
    Hypertension; 2006 Aug; 48(2):203-4. PubMed ID: 16785329
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific aspects of high blood pressure in the elderly.
    Blacher J; Safar M
    J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3 Suppl 1():S10-5. PubMed ID: 12428216
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antihypertensive therapy in the elderly: results of large trials].
    Leonetti G; Cuspidi C; Facchini M
    Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.